Sionna Moves SION-451 + SION-2222 Into Phase 2a After August Setback

Sionna will start a Q1 2027 Phase 2a trial of SION-451 plus SION-2222 after a missed Trikafta add-on study. A 46% staff cut extends cash into 2H 2029.